Mediar Therapeutics

New perspective. Novel targets. Clinical trials.

Mediar Therapeutics was founded in 2019, is headquartered in Cambridge, United States, lists 11–50 employees, and has $282.0M in recorded funding across 4 rounds.

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$282.0M
Last Round
$76.0M Series BJun 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 11 investors for this company. The full record is or through the API.

About

Mediar Therapeutics is pioneering first-in-class antibody treatments for fibrosis by targeting the myofibroblast — the cell responsible for scarring and disease progression. Founded from research at Mass General and Brigham and Women's Hospitals, the company focuses on IPF, systemic sclerosis, and kidney fibrosis.

Summary

Mediar Therapeutics is a Biotech company based in Cambridge, United States, founded in 2019. It lists 11–50 employees. It has raised $282.0M in total across 4 rounds, most recently a $76.0M Series B round in Jun 2026. Investors include ICG Life Sciences, Amplitude Ventures and Intermediate Capital Group.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2026
$76.0M

Sign up to see all 4 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mediar Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/mediar-therapeutics"><img src="https://indexed.vc/api/badge/company/mediar-therapeutics" alt="Mediar Therapeutics on Indexed.vc" width="260" height="76" /></a>